Used primarily in the development of anti-inflammatory and analgesic medications, this compound exhibits inhibitory activity against cyclooxygenase (COX) enzymes, particularly COX-2, making it a candidate for treating conditions involving pain and inflammation without significant gastrointestinal side effects. It has been investigated for use in chronic inflammatory diseases such as arthritis. Additionally, due to its metabolic stability and favorable pharmacokinetic profile, it serves as a lead compound in optimizing new derivatives with enhanced efficacy and safety. Research also explores its potential in cancer prevention owing to the role of COX-2 inhibition in reducing tumor progression in certain cancers.